Sagen, J., Raeder, H., Hathout, E., Shehadeh, N., Gudmundsson, K., Baevre, H., . . . Njølstad, P. (2004). Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: Patient characteristics and initial response to sulfonylurea therapy.
Chicagoスタイル(17版)引用形式Sagen, J., et al. Permanent Neonatal Diabetes Due to Mutations in KCNJ11 Encoding Kir6.2: Patient Characteristics and Initial Response to Sulfonylurea Therapy. 2004.
MLA(9版)引用形式Sagen, J., et al. Permanent Neonatal Diabetes Due to Mutations in KCNJ11 Encoding Kir6.2: Patient Characteristics and Initial Response to Sulfonylurea Therapy. 2004.
警告: この引用は必ずしも正確ではありません.